文献速递产科母胎医学

基于合并症的筛查工具预测分娩时严重孕产妇并发症

A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery.
PubMed 文献 · Am J Obstet Gynecol · 2019-06-20

本研究在单中心纳入2018年2月至7月孕周≥23周分娩的2828例孕妇,由护士计算产科合并症指数并在每12小时轮班时复评,评估其与严重孕产妇并发症的关联。结果显示指数每增加1分,严重孕产妇并发症的比值增加1.55倍(95%CI 1.42-1.70),c统计量为0.83(95%CI 0.76-0.89),提示该工具可在临床中前瞻性识别高危孕妇。

要点

  • 产科合并症指数评分范围为0-15分,队列中位评分为1分(四分位距0-3)。
  • 发生严重孕产妇并发症者中位评分为5分(四分位距3-7),未发生者为1分(四分位距0-3),P<.01。
  • 严重孕产妇并发症频率从评分0分的0.41%升至评分≥9分的18.75%。

核心结论

  • 产科合并症指数可在临床环境中前瞻性识别有严重孕产妇并发症风险的孕妇。
  • 该指数的优势在于能整合多种叠加合并症并突出患者病情的累积风险。
  • 常规临床使用产科合并症指数有潜力识别需要加强监测和针对性照护以预防不良母体结局的高危孕妇。

研究设计与样本

  • 单中心三级保健中心研究,纳入2018年2月至7月孕周≥23周就诊于产房的全部孕妇。
  • 由患者的主要产房护士评估合并症并计算产科合并症指数,每12小时轮班时重新计算。
  • 由多学科临床医生小组根据美国妇产科医师学会(American College of Obstetrics and Gynecology)和母胎医学会(Society for Maternal-Fetal Medicine)共识定义判定是否发生严重孕产妇并发症,且对产科合并症指数评分设盲。
  • 分析产科合并症指数评分与严重孕产妇并发症发生之间的关联。

主要发现

  • 研究共纳入2828例孕妇,其中1.73%(n=49)发生严重孕产妇并发症。
  • 研究队列中产科合并症指数范围为0-15分,中位评分为1分(四分位距0-3)。
  • 发生严重孕产妇并发症者的中位产科合并症指数评分为5分(四分位距3-7),未发生者为1分(四分位距0-3),P<.01。
  • 严重孕产妇并发症频率从评分0分的0.41%升至评分≥9分的18.75%。
  • 评分每增加1分,患者发生严重孕产妇并发症的比值增加1.55倍(95%CI 1.42-1.70)。

关键数值与推荐

  • 严重孕产妇并发症判定依据美国妇产科医师学会和母胎医学会共识定义。
  • 评分每增加1分,严重孕产妇并发症的比值增加1.55倍(95%CI 1.42-1.70)。
  • 产科合并症指数评分的c统计量为0.83(95%CI 0.76-0.89)。

临床怎么用

  • 作者认为,产科合并症指数可在临床环境中前瞻性识别有严重孕产妇并发症风险的孕妇。
  • 作者认为,常规临床使用产科合并症指数有潜力识别需要加强监测和针对性照护以预防不良母体结局的高危孕妇。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The obstetric comorbidity index summarizes the burden of maternal comorbidities into a single number and holds promise as a maternal risk-assessment tool. OBJECTIVE: The aim of this study was to assess the clinical performance of this comorbidity-based screening tool to accurately identify women on labor and delivery who are at risk of severe maternal morbidity on labor and delivery in real time. STUDY DESIGN: All patients with pregnancies ≥23 weeks gestation presenting to labor and delivery at a single tertiary-care center from February through July 2018 were included in the study. The patient's primary labor and delivery nurse assessed patient comorbidities and calculated the patient's obstetric comorbidity index. The score was recalculated at each 12-hour shift change. A multidisciplinary panel of clinicians determined whether patients experienced severe maternal morbidity based on the American College of Obstetrics and Gynecology and Society for Maternal-Fetal Medicine consensus definition, blinded to the patient's obstetric comorbidity index score. We analyzed the association between the obstetric comorbidity index score and the occurrence of severe maternal morbidity. RESULTS: The study included 2828 women, of whom 1.73% experience severe maternal morbidity (n=49). The obstetric comorbidity index ranged from 0-15 for women in the study cohort, with a median obstetric comorbidity index of 1 (interquartile range, 0-3). The median obstetric comorbidity index score for women who experienced the severe maternal morbidity was 5 (interquartile range, 3-7) compared with a median of 1 (interquartile range, 0-3) for those without severe maternal morbidity (P<.01). The frequency of severe maternal morbidity increased from 0.41% for those with a score of 0 to 18.75% for those with a score ≥9. For every 1-point increase in the score, patients experienced a 1.55 increase in odds of severe maternal morbidity (95% confidence interval, 1.42-1.70). The c-statistic for the obstetric comorbidity index score was 0.83 (95% confidence interval, 0.76-0.89), which indicated strong discrimination. CONCLUSION: The obstetric comorbidity index can prospectively identify women at risk of severe maternal morbidity in a clinical setting. A particular strength of the obstetric comorbidity index is its ability to integrate multiple compounding comorbidities and highlight the cumulative risk that is associated with the patients' conditions. Routine clinical use of the obstetric comorbidity index has the potential to identify at-risk women whose condition warrants increased surveillance and targeted care to prevent adverse maternal outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Easter SR, Bateman BT, Sweeney VH, et al. A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery. Am J Obstet Gynecol. 2019. PMID: 31229427. doi:10.1016/j.ajog.2019.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。